Antares Faces Records Suit Over Testosterone Drug Troubles

Jan 30, 2019 - Law360
A regulatory smackdown dealt to Antares Pharma Inc. over a new injectable testosterone treatment led a shareholder to file a books and records suit in Delaware Chancery Court on Wednesday with the goal of investigating alleged misstatements about the drug’s clinical trials. Read More